Cybin (NYSE:CYBN – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $5.00 price objective on the stock.
Separately, Cantor Fitzgerald reissued an “overweight” rating on shares of Cybin in a research note on Friday, June 21st.
Check Out Our Latest Report on Cybin
Cybin Price Performance
Cybin (NYSE:CYBN – Get Free Report) last released its quarterly earnings data on Wednesday, June 26th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). On average, analysts forecast that Cybin will post -0.09 earnings per share for the current year.
Hedge Funds Weigh In On Cybin
A number of institutional investors and hedge funds have recently added to or reduced their stakes in CYBN. PEAK6 Investments LLC purchased a new stake in Cybin in the first quarter valued at $95,000. AWM Investment Company Inc. purchased a new stake in Cybin in the first quarter valued at $930,000. Rosalind Advisors Inc. raised its position in Cybin by 38.3% in the second quarter. Rosalind Advisors Inc. now owns 19,300,000 shares of the company’s stock valued at $5,230,000 after purchasing an additional 5,340,000 shares during the period. Ikarian Capital LLC purchased a new stake in Cybin in the first quarter valued at $5,770,000. Finally, RA Capital Management L.P. purchased a new stake in Cybin in the first quarter valued at $24,041,000. Institutional investors and hedge funds own 17.94% of the company’s stock.
About Cybin
Cybin Inc is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc is based in Toronto, Canada.
Further Reading
- Five stocks we like better than Cybin
- Best Stocks Under $5.00
- Invest Like Congress: 2 ETFs to Add to Your Watchlist
- The Role Economic Reports Play in a Successful Investment Strategy
- AI Boom or Bubble? Strategies for Success in a Volatile Sector
- What is a Bond Market Holiday? How to Invest and Trade
- Oilfield Infrastructure Stock Soars Over 50% on Bold Acquisition
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.